Pharma
Big Pharma tackles Super Bowl advertising
This year’s game was punctuated by more pharma commercials, though some experts wonder if regulations might squash that momentum.
This year’s game was punctuated by more pharma commercials, though some experts wonder if regulations might squash that momentum.
The girls are fighting…again.
From semaglutide vs. tirzepatide to Ozempic vs. Wegovy.
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
It was a busy Q1 for the retail pharmacy giant.
Because who doesn’t prefer swallowing a pill over getting a shot?
The telehealth provider has sold compounded versions of Novo’s GLP-1 since 2022.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.